OxTalks is Changing
During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
Restoring the balance with Regulatory T Cell Therapies
Quell Therapeutics is a London based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date:
18 January 2024, 12:00
Venue:
Seminar room
Speaker:
Luke Devey (Chief Medical Officer)
Organising department:
Department of Paediatrics
Organiser:
Sheena Lee (MSD Business Partnerships Office)
Booking required?:
Not required
Booking url:
https://forms.office.com/e/suZ1J5CiU1
Cost:
None
Audience:
Members of the University only
Editor:
Laura Borg
